HemoCath
HemoCath is dedicated to improving healthcare for critically ill patients and people living with heart failure by pioneering innovations at the intersection of Digital Health and MedTech. They develop the Swan-HemoCath™ Critical Care AI Platform, which integrates pulmonary artery catheters with AI-guided diagnosis, treatment, and monitoring to enhance patient outcomes, reduce hospital stays, and lower healthcare costs. Inspired by Dr. Jeremy Swan's legacy, the company aims to advance critical care with next-generation pulmonary artery catheters and continuous monitoring solutions.
Industries
Nr. of Employees
small (1-50)
Patents
Dual sensor system for continuous blood pressure monitoring during transcatheter heart valve therapies
US-11406271-B2
View DetailsSystem and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization
US-11272847-B2
View DetailsSystem and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization
US-11197619-B2
View DetailsSystem and apparatus comprising a multisensor guidewire for use in interventional cardiology
US-10722175-B2
View DetailsSystem and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization
US-10463259-B2
View Details
Dual sensor system for continuous blood pressure monitoring during transcatheter heart valve therapies
US-11406271-B2
View DetailsSystem and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization
US-11272847-B2
View DetailsSystem and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization
US-11197619-B2
View DetailsSystem and apparatus comprising a multisensor guidewire for use in interventional cardiology
US-10722175-B2
View DetailsSystem and apparatus comprising a multi-sensor catheter for right heart and pulmonary artery catheterization
US-10463259-B2
View DetailsProducts
Minimally invasive pulmonary artery (PA) catheter (prototype)
A small-diameter (4F) pulmonary artery catheter engineered for insertion via a brachial vein to measure pulmonary artery pressure and central venous pressure continuously; designed for portability and MRI compatibility. Prototype status; not approved for clinical use.
Minimally invasive pulmonary artery (PA) catheter (prototype)
A small-diameter (4F) pulmonary artery catheter engineered for insertion via a brachial vein to measure pulmonary artery pressure and central venous pressure continuously; designed for portability and MRI compatibility. Prototype status; not approved for clinical use.
Services
A cloud platform that ingests continuous catheter-derived hemodynamic data, applies AI analytics for diagnosis and treatment support, and provides remote monitoring and data aggregation for clinical teams and researchers.
A cloud platform that ingests continuous catheter-derived hemodynamic data, applies AI analytics for diagnosis and treatment support, and provides remote monitoring and data aggregation for clinical teams and researchers.
Expertise Areas
- Hemodynamic monitoring
- Critical care monitoring
- Heart failure management
- Digital health and AIoT platform development
Key Technologies
- Pulmonary artery catheterization
- Hemodynamic measurement (PAP, CVP)
- Continuous physiological signal acquisition
- Cloud-based AI analytics